Investors & Media

Overview

Altamira Therapeutics is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in RNA therapeutics, allergy and viral infections, and inner ear disorders. The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Altamira Therapeutics Ltd. trade on the NASDAQ Capital Market under the symbol “CYTO.”

Investor Contact

Primary IR Contacts

Stephen Kilmer
E-Mail: sjk@altamiratherapeutics.com or
Investors@altamiratherapeutics.com

Stock Quote

NASDAQ: CYTO

Recent Press Releases